JPS60260520A - 医薬組成物 - Google Patents
医薬組成物Info
- Publication number
- JPS60260520A JPS60260520A JP59117957A JP11795784A JPS60260520A JP S60260520 A JPS60260520 A JP S60260520A JP 59117957 A JP59117957 A JP 59117957A JP 11795784 A JP11795784 A JP 11795784A JP S60260520 A JPS60260520 A JP S60260520A
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- stalk
- drug composition
- group
- accumulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940079593 drug Drugs 0.000 title abstract description 12
- 239000003814 drug Substances 0.000 title abstract description 12
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 235000005769 Japanese ginseng Nutrition 0.000 claims description 11
- 241000168720 Panax japonicus Species 0.000 claims description 11
- 235000003174 Panax japonicus Nutrition 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- 238000009825 accumulation Methods 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000002503 metabolic effect Effects 0.000 abstract description 5
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 abstract description 4
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 abstract description 4
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 abstract description 2
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 abstract description 2
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 abstract description 2
- 229960002045 bergapten Drugs 0.000 abstract description 2
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 abstract description 2
- 150000003943 catecholamines Chemical class 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 abstract description 2
- 229960002748 norepinephrine Drugs 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 230000003405 preventing effect Effects 0.000 abstract description 2
- 241001063953 Angelica shikokiana Species 0.000 abstract 3
- 210000000056 organ Anatomy 0.000 abstract 2
- 239000003925 fat Substances 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 13
- 241000700159 Rattus Species 0.000 description 11
- 239000002285 corn oil Substances 0.000 description 11
- 235000005687 corn oil Nutrition 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 description 9
- 235000008434 ginseng Nutrition 0.000 description 9
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- -1 lipid peroxide Chemical class 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000277269 Oncorhynchus masou Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229940029982 garlic powder Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59117957A JPS60260520A (ja) | 1984-06-07 | 1984-06-07 | 医薬組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59117957A JPS60260520A (ja) | 1984-06-07 | 1984-06-07 | 医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60260520A true JPS60260520A (ja) | 1985-12-23 |
| JPH043365B2 JPH043365B2 (enrdf_load_stackoverflow) | 1992-01-23 |
Family
ID=14724425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59117957A Granted JPS60260520A (ja) | 1984-06-07 | 1984-06-07 | 医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60260520A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006082743A1 (ja) * | 2005-02-04 | 2006-08-10 | Takara Bio Inc. | 治療剤 |
| JP2016172711A (ja) * | 2015-03-16 | 2016-09-29 | 国立大学法人九州大学 | 血液凝固阻害剤及び血液凝固阻害剤の生産方法 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1176500A (en) * | 1998-11-11 | 2000-05-29 | Manabu Nomura | Health-promoting foods |
| JP6065289B2 (ja) * | 2013-05-09 | 2017-01-25 | 国立大学法人九州大学 | 抽出方法、美白化粧品を生産する方法及びヘアケア製品を生産する方法 |
-
1984
- 1984-06-07 JP JP59117957A patent/JPS60260520A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006082743A1 (ja) * | 2005-02-04 | 2006-08-10 | Takara Bio Inc. | 治療剤 |
| JP2016172711A (ja) * | 2015-03-16 | 2016-09-29 | 国立大学法人九州大学 | 血液凝固阻害剤及び血液凝固阻害剤の生産方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH043365B2 (enrdf_load_stackoverflow) | 1992-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002179586A (ja) | リパーゼ阻害剤 | |
| CN106074971A (zh) | 一种降血糖中药组合物及制备方法与应用 | |
| JP3768795B2 (ja) | キサンチンオキシダーゼ阻害剤 | |
| WO2012090194A2 (en) | Compositions and methods for treating a skin disorder | |
| US6329000B1 (en) | Extract of pine needle and the use thereof | |
| GB2503628A (en) | Pharmaceutical compostion for controlling blood sugar, blood lipid and body weight | |
| CN106822599A (zh) | 一种环草石斛提取物及其抗糖尿病用途 | |
| US20200188468A1 (en) | A coated costus composition enriched with triterpenoids and a method of preparation of the same | |
| CN102319289B (zh) | 肉桂多酚等组成的降血糖中药组合物及其制备方法 | |
| JP6369931B2 (ja) | 抗肥満剤 | |
| CN100467031C (zh) | 牛蒡子总木脂素的医药用途 | |
| JP4371431B2 (ja) | 抗アレルギー性組成物 | |
| KR102234860B1 (ko) | 싸리 추출물을 포함하는 근위축 예방 및 치료용 조성물 | |
| JPS60260520A (ja) | 医薬組成物 | |
| KR20070026329A (ko) | 우울증 치료를 위한 선인장 식물체 일부 및／또는 그추출물의 용도 | |
| JP3204348B2 (ja) | 動脈硬化抑制剤及びこれを含む食品又は医薬 | |
| JP4601069B2 (ja) | 高脂血症治療のための相乗効果的医薬組成物 | |
| JP2001261569A (ja) | 抗肥満症剤 | |
| RU2321419C1 (ru) | ЭКСТРАКТ Cetraria islandica (L.) Ach. СУХОЙ, ТАБЛЕТИРОВАННАЯ ФОРМА | |
| JP4610730B2 (ja) | カルシウム補給用の組成物 | |
| CN105963330A (zh) | 神秘果制剂及其应用 | |
| CN112089783A (zh) | 中药组合物在制备预防或/和治疗肥胖的药物中的应用 | |
| US10517826B2 (en) | Anthostema senegalense-based composition for use as an anti-AIDS drug | |
| CN109432082A (zh) | 一种防治化学性肝损伤的药物组合物 | |
| CN103432541A (zh) | 一种蘘荷花苞提取物的降血脂新用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |